U.S Physical Therapy Price to Sales Ratio 2012-2025 | USPH
Historical PS ratio values for U.S Physical Therapy (USPH) over the last 10 years. The current P/S ratio for U.S Physical Therapy as of February 13, 2026 is .
| U.S Physical Therapy P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-02-13 | 86.94 | 1.74 | |
| 2025-09-30 | 84.42 | $50.08 | 1.69 |
| 2025-06-30 | 77.30 | $48.26 | 1.60 |
| 2025-03-31 | 71.10 | $46.36 | 1.53 |
| 2024-12-31 | 86.65 | $44.58 | 1.94 |
| 2024-09-30 | 82.26 | $43.52 | 1.89 |
| 2024-06-30 | 89.35 | $42.38 | 2.11 |
| 2024-03-31 | 108.67 | $42.33 | 2.57 |
| 2023-12-31 | 89.30 | $43.36 | 2.06 |
| 2023-09-30 | 87.51 | $43.32 | 2.02 |
| 2023-06-30 | 115.32 | $44.05 | 2.62 |
| 2023-03-31 | 92.65 | $43.83 | 2.11 |
| 2022-12-31 | 76.34 | $42.61 | 1.79 |
| 2022-09-30 | 71.27 | $41.81 | 1.70 |
| 2022-06-30 | 101.90 | $40.82 | 2.50 |
| 2022-03-31 | 92.42 | $39.84 | 2.32 |
| 2021-12-31 | 88.42 | $38.39 | 2.30 |
| 2021-09-30 | 101.97 | $37.47 | 2.72 |
| 2021-06-30 | 106.46 | $36.20 | 2.94 |
| 2021-03-31 | 95.35 | $32.89 | 2.90 |
| 2020-12-31 | 109.82 | $32.97 | 3.33 |
| 2020-09-30 | 79.35 | $33.39 | 2.38 |
| 2020-06-30 | 73.99 | $34.09 | 2.17 |
| 2020-03-31 | 63.02 | $37.46 | 1.68 |
| 2019-12-31 | 104.08 | $37.80 | 2.75 |
| 2019-09-30 | 118.51 | $37.49 | 3.16 |
| 2019-06-30 | 111.02 | $37.23 | 2.98 |
| 2019-03-31 | 94.91 | $36.41 | 2.61 |
| 2018-12-31 | 92.26 | $35.85 | 2.57 |
| 2018-09-30 | 106.69 | $35.27 | 3.02 |
| 2018-06-30 | 86.18 | $34.54 | 2.49 |
| 2018-03-31 | 72.80 | $33.75 | 2.16 |
| 2017-12-31 | 64.47 | $32.95 | 1.96 |
| 2017-09-30 | 54.71 | $31.53 | 1.74 |
| 2017-06-30 | 53.60 | $30.40 | 1.76 |
| 2017-03-31 | 57.59 | $29.34 | 1.96 |
| 2016-12-31 | 61.91 | $28.54 | 2.17 |
| 2016-09-30 | 55.15 | $28.26 | 1.95 |
| 2016-06-30 | 52.81 | $27.97 | 1.89 |
| 2016-03-31 | 43.49 | $27.46 | 1.58 |
| 2015-12-31 | 46.78 | $26.75 | 1.75 |
| 2015-09-30 | 39.00 | $26.25 | 1.49 |
| 2015-06-30 | 47.44 | $25.83 | 1.84 |
| 2015-03-31 | 41.02 | $25.51 | 1.61 |
| 2014-12-31 | 36.13 | $24.98 | 1.45 |
| 2014-09-30 | 30.38 | $24.17 | 1.26 |
| 2014-06-30 | 29.25 | $23.25 | 1.26 |
| 2014-03-31 | 29.46 | $22.38 | 1.32 |
| 2013-12-31 | 29.94 | $21.87 | 1.37 |
| 2013-09-30 | 26.30 | $21.32 | 1.23 |
| 2013-06-30 | 23.31 | $21.09 | 1.11 |
| 2013-03-31 | 22.56 | $20.94 | 1.08 |
| 2012-12-31 | 23.04 | $20.99 | 1.10 |
| 2012-09-30 | 22.69 | $20.47 | 1.11 |
| 2012-06-30 | 20.81 | $20.24 | 1.03 |
| 2012-03-31 | 18.80 | $19.86 | 0.95 |
| 2011-12-31 | 15.98 | $19.32 | 0.83 |
| 2011-09-30 | 14.97 | $19.20 | 0.78 |
| 2011-06-30 | 19.91 | $18.73 | 1.06 |
| 2011-03-31 | 17.93 | $18.30 | 0.98 |
| 2010-12-31 | 15.84 | $17.80 | 0.89 |
| 2010-09-30 | 13.36 | $17.58 | 0.76 |
| 2010-06-30 | 13.49 | $17.43 | 0.77 |
| 2010-03-31 | 13.91 | $17.32 | 0.80 |
| 2009-12-31 | 13.53 | $17.06 | 0.79 |
| 2009-09-30 | 12.05 | $16.76 | 0.72 |
| 2009-06-30 | 11.79 | $16.31 | 0.72 |
| 2009-03-31 | 7.74 | $15.80 | 0.49 |
| 2008-12-31 | 10.65 | $15.59 | 0.68 |
| 2008-09-30 | 13.88 | $15.39 | 0.90 |
| 2008-06-30 | 13.12 | $14.69 | 0.89 |
| 2008-03-31 | 11.53 | $13.80 | 0.84 |
| 2007-12-31 | 11.49 | $12.99 | 0.88 |
| 2007-09-30 | 11.83 | $12.12 | 0.98 |
| 2007-06-30 | 10.77 | $11.73 | 0.92 |
| 2007-03-31 | 11.13 | $11.60 | 0.96 |
| 2006-12-31 | 9.79 | $11.39 | 0.86 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.322B | $0.671B |
| U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Quest Diagnostics (DGX) | United States | $23.013B | 21.00 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| Encompass Health (EHC) | United States | $11.082B | 20.17 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| RadNet (RDNT) | United States | $5.365B | 183.00 |
| LifeStance Health (LFST) | United States | $2.735B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Astrana Health (ASTH) | United States | $1.057B | 98.84 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |